July 21, 2017 - By Richard Conner
Sunlink Health Systems Incorporated (NYSEMKT:SSY) had an increase of 98.06% in short interest. SSY’s SI was 51,100 shares in July as released by FINRA. Its up 98.06% from 25,800 shares previously. With 23,000 avg volume, 2 days are for Sunlink Health Systems Incorporated (NYSEMKT:SSY)’s short sellers to cover SSY’s short positions. The SI to Sunlink Health Systems Incorporated’s float is 0.81%. About 202 shares traded. SunLink Health Systems, Inc. (NYSEMKT:SSY) has risen 170.00% since July 21, 2016 and is uptrending. It has outperformed by 153.30% the S&P500.
The stock of Vishay Intertechnology (NYSE:VSH) is a huge mover today! About 430,150 shares traded. Vishay Intertechnology (NYSE:VSH) has risen 33.97% since July 21, 2016 and is uptrending. It has outperformed by 17.27% the S&P500.The move comes after 9 months negative chart setup for the $2.64B company. It was reported on Jul, 21 by Barchart.com. We have $16.40 PT which if reached, will make NYSE:VSH worth $237.60 million less.
Analysts await Vishay Intertechnology (NYSE:VSH) to report earnings on August, 3 before the open. They expect $0.33 earnings per share, up 43.48% or $0.10 from last year’s $0.23 per share. VSH’s profit will be $48.35M for 13.65 P/E if the $0.33 EPS becomes a reality. After $0.28 actual earnings per share reported by Vishay Intertechnology for the previous quarter, Wall Street now forecasts 17.86% EPS growth.
Vishay Intertechnology, Inc. is a global maker and supplier of discrete semiconductors and passive components. The company has market cap of $2.64 billion. The Firm operates through five product divisions: MOSFETs, Diodes, Optoelectronic Components, Resistors & Inductors and Capacitors. It has a 49.04 P/E ratio. MOSFETs segment offers low-voltage TrenchFET MOSFETs and high-voltage MOSFETs.
Investors sentiment increased to 1.02 in 2016 Q4. Its up 0.03, from 0.99 in 2016Q3. It increased, as 21 investors sold Vishay Intertechnology shares while 85 reduced holdings. 31 funds opened positions while 77 raised stakes. 152.26 million shares or 0.88% more from 150.93 million shares in 2016Q3 were reported. Convergence Invest Prns Llc owns 179,514 shares or 0.4% of their US portfolio. Mason Street Llc holds 0.03% or 62,470 shares. Invesco Ltd holds 0.01% or 2.68M shares in its portfolio. Thompson Davis Inc accumulated 0.03% or 1,000 shares. Bnp Paribas Arbitrage Sa reported 0.01% in Vishay Intertechnology (NYSE:VSH). Credit Agricole S A has 0.01% invested in Vishay Intertechnology (NYSE:VSH) for 113,946 shares. 53,952 were accumulated by State Treasurer State Of Michigan. Shufro Rose And Ltd Llc invested in 0.03% or 18,200 shares. Needham Invest Management Lc reported 0.29% stake. Tiaa Cref Mngmt Ltd Co holds 392,323 shares. Geode Mngmt Limited Liability owns 1.22 million shares. The Massachusetts-based Liberty Mutual Gp Asset Mgmt has invested 0.03% in Vishay Intertechnology (NYSE:VSH). Morgan Stanley invested 0% in Vishay Intertechnology (NYSE:VSH). Voya Mngmt Ltd has invested 0% in Vishay Intertechnology (NYSE:VSH). The California-based Whittier Trust has invested 0% in Vishay Intertechnology (NYSE:VSH).
Among 5 analysts covering Vishay Intertechnology (NYSE:VSH), 0 have Buy rating, 2 Sell and 3 Hold. Therefore 0 are positive. Vishay Intertechnology had 6 analyst reports since August 5, 2015 according to SRatingsIntel. TheStreet downgraded the stock to “Hold” rating in Saturday, September 5 report. Bank of America downgraded the stock to “Underperform” rating in Wednesday, August 5 report. The stock of Vishay Intertechnology (NYSE:VSH) earned “Hold” rating by Stifel Nicolaus on Wednesday, November 9. The stock of Vishay Intertechnology (NYSE:VSH) earned “Sell” rating by Citigroup on Friday, October 23.
Since February 22, 2017, it had 0 insider buys, and 5 selling transactions for $3.96 million activity. 50,000 shares were sold by PAUL GERALD, worth $838,000 on Friday, May 12. 10,000 shares valued at $165,500 were sold by SHOSHANI ZIV on Wednesday, February 22. $859,770 worth of Vishay Intertechnology (NYSE:VSH) shares were sold by ZANDMAN MARC.
SunLink Health Systems, Inc., through its subsidiaries, owns businesses, which provide healthcare services in various markets in the United States. The company has market cap of $14.51 million. The Company’s divisions include Healthcare Facilities, Specialty Pharmacy, and Corporate and Other. It has a 10.8 P/E ratio. The Company’s Specialty Pharmacy segment is operated through its subsidiary, SunLink ScriptsRx, LLC .
Investors sentiment decreased to 0.33 in 2016 Q4. Its down 2.67, from 3 in 2016Q3. It worsened, as 2 investors sold SunLink Health Systems, Inc. shares while 1 reduced holdings. 0 funds opened positions while 1 raised stakes. 300,406 shares or 3.74% less from 312,073 shares in 2016Q3 were reported. Renaissance Ltd Liability Corporation holds 0% in SunLink Health Systems, Inc. (NYSEMKT:SSY) or 73,600 shares. Creative Planning has invested 0% in SunLink Health Systems, Inc. (NYSEMKT:SSY). Monarch Capital Mgmt owns 0.01% invested in SunLink Health Systems, Inc. (NYSEMKT:SSY) for 32,285 shares. California Employees Retirement Systems has invested 0% in SunLink Health Systems, Inc. (NYSEMKT:SSY). Wells Fargo Mn holds 0% or 453 shares. Granite Invest Ltd Com holds 0% of its portfolio in SunLink Health Systems, Inc. (NYSEMKT:SSY) for 50,147 shares. Vanguard Group invested 0% of its portfolio in SunLink Health Systems, Inc. (NYSEMKT:SSY). State Street holds 10,300 shares. Acadian Asset Mgmt Limited Company, Massachusetts-based fund reported 9,327 shares. Earnest Ptnrs Ltd has invested 0% in SunLink Health Systems, Inc. (NYSEMKT:SSY). Manufacturers Life Ins Com The stated it has 693 shares. Financial Bank Of America Corp De stated it has 1 shares or 0% of all its holdings. Geode Capital Mgmt Lc holds 0% of its portfolio in SunLink Health Systems, Inc. (NYSEMKT:SSY) for 19,190 shares. Blackrock Institutional Tru Na reported 1 shares or 0% of all its holdings.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.